Abstract
The protein nerve growth factor (NGF) is known to be essential for the maturation and maintenance of adrenergic neurones1 and for the development of sensory neurones during critical stages of embryonic life2–4. The investigation of the physiological importance of NGF for the development of sensory neurones has been hampered so far by the lack of biochemical marker substances for these neurones. The demonstration that the undecapeptide substance P(SP) is present in sensory neurones5,6 suggests that it might be such a marker. SP is synthesized in dorsal root ganglia (DRG)7 and transported to the terminals of C-fibres located in the dorsal horn of the spinal cord and in the skin8. Its release can be demonstrated from the central9,10 and peripheral endings11 of sensory nerve fibres which seem to have an important role in pain perception12,13. We have investigated the effects of NGF and of purified anti-NGF antibodies on the content of SP in rat DRG and in their respective target organs, namely the spinal cord and the skin. The effects on sympathetic ganglia were included in order to control the effectiveness of both NGF and its antibody. We report here that NGF leads to an increase in SP in spinal ganglia, as previously shown by Kessler and Black14. However, in contrast to these authors, we describe that the administration of anti-NGF antibodies produces a marked reduction of the SP content in sensory neurones and in their respective nerve terminals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mobley, W. C., Server, A. C., Ishi, D. N., Riopelle, R. J. & Shooter, E. M. New Engl. J. Med. 297, 1096–1104, 1149–1158, 1211–1218 (1977).
Levi-Montalcini, R. & Angeletti, P. U. Physiol. Rev. 48, 534–569 (1968).
Herrup, K. & Shooter, E. M. J. Cell Biol. 67, 118–125 (1975).
Barde, Y. A., Edgar, D. & Thoenen, H. Proc. natn. Acad. Sci. U.S.A. 77, 1199–1203 (1980).
Hökfelt, T., Kellerth, J. O., Nilsson, G. & Pernow, B. Science 190, 889–890 (1975).
Hökfelt, T. et al. Neuroscience 1, 131–136 (1976).
Harmar, A., Schofield, J. G. & Keen, P. Nature 284, 267–269 (1980).
Takahashi, T. & Otsuka, M. Brain Res. 87, 1–11 (1975).
Gamse, R., Molnar, A. & Lembeck, F. Life Sci. 25, 629–636 (1979).
Theriault, E., Otsuka, M. & Jessell, T. Brain Res. 170, 209–213 (1979).
Bill, A., Stjernschantz, J., Mandahl, A., Brodin, E. & Nilsson, G. Acta physiol. scand. (in the press).
Nicoll, R. A., Schenker, C. & Leeman, S. E. A. Rev. Neurosci. 3, 227–268 (1980).
Henry, J. L. Brain Res. 114, 439–452 (1976).
Kessler, J. A. & Black, I. B. Proc. natn. Acad. Sci. U.S.A. 77, 649–652 (1980).
Bocchini, V. & Angeletti, P. U. Proc. natn. Acad. Sci. U.S.A. 64, 787–794 (1969).
Stöckel, K., Gagnon, C., Guroff, G. & Thoenen, H. J. Neurochem. 26, 1207–1211 (1976).
Mueller, R. A., Thoenen, H. & Axelrod, J. J. Pharmac. exp. Ther. 169, 74–79 (1969).
Mroz, E. A., Brownstein, M. J. & Leeman, S. E. in Substance P (eds von Euler, U. S. & Pernow, B.) 147–155 (Raven, New York, 1976).
Lowry, O. H., Rosebrough, N. H., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265–275 (1951).
Suda, K., Barde, Y. A. & Thoenen, H. Proc. natn. Acad. Sci. U.S.A. 75, 4042–4046 (1978).
Fenton, E. L. Expl Cell Res. 59, 383–392 (1970).
Thoenen, H., Angeletti, P. U., Levi-Montalcini, R. & Kettler, R. Proc. natn. Acad. Sci. U.S.A. 68, 1598–1602 (1971).
Goedert, M., Otten, U. & Thoenen, H. Brain Res. 148, 264–268 (1978).
Stöckel, K., Schwab, M. & Thoenen, H. Brain Res. 99, 1–16 (1975).
Brunso-Bechtold, J. K. & Hamburger, V. Proc. natn. Acad. Sci. U.S.A. 76, 1494–1496 (1979).
Hökfelt, T., Johansson, O., Ljungdahl, Å., Lundberg, J. M. & Schultzberg, N. Nature 284, 515–521 (1980).
Schultzberg, M., Ebendal, T., Hökfelt, T., Nilsson, G. & Pfenninger, K. J. Neurocytology 7, 107–117 (1978).
Schwartz, J. P. & Costa, E. Brain Res. 170, 198–202 (1979).
Jessell, T. M., Iversen, L. L. & Cuello, A. C. Brain Res. 152, 183–188 (1978).
Gamse, R., Holzer, P. & Lembeck, F. Br. J. Pharmac. 68, 207–213 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Otten, U., Goedert, M., Mayer, N. et al. Requirement of nerve growth factor for development of substance P-containing sensory neurones. Nature 287, 158–159 (1980). https://doi.org/10.1038/287158a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/287158a0
This article is cited by
-
Neuronal plasticity of the “brain–skin connection”: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways
Journal of Molecular Medicine (2007)
-
Regional versus generalized muscle pain syndromes
Current Review of Pain (1999)
-
Neuropeptides in the uveal tract
Eye (1988)
-
Nerve growth factor protects adult sensory neurons from cell death and atrophy caused by nerve injury
Journal of Neurocytology (1987)
-
Morphological changes of sensory CGRP-immunoreactive and sympathetic nerves in peripheral tissues following chronic denervation
Histochemistry (1986)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.